New vaginal device shows promise for yeast infections in small trial
NCT ID NCT05507333
First seen Nov 01, 2025 · Last updated Jun 24, 2026 · Updated 33 times
Summary
This study tested a vaginal pessary (Gedea) in 26 women with yeast infections. Participants used the device daily for 6 days. Researchers checked if symptoms like itching and burning went away by day 7 to 14. The goal was to see if the device could safely treat the infection without medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VULVOVAGINAL CANDIDIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CTC MTC
Uppsala, 75237, Sweden
-
Carlanderska
Gothenburg, 405 45, Sweden
-
Danderyds sjukhus
Stockholm, 182 88, Sweden
-
KS Huddinge
Stockholm, 141 86, Sweden
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Gedea pessary (a vaginal insert device)
What this could lead to
If it works, this could offer a new non-drug option for treating yeast infections, potentially reducing symptoms and clearing the infection.
What could go wrong
This is a small, early-phase study with only 26 participants, so results may not apply to everyone. The device may not work as well as standard antifungal treatments.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.